Risk of C1q variation in systemic lupus erythematosus: a meta-analysis with Trial Sequential Analysis.

Wang, Hong; Wang, Tingrui; Wang, Haili; Wu, Yue; Wu, Lingling; Ling, Huayun; Ye, Dong-Qing; Wang, Bin

Wang, Hong; Wang, Tingrui; Wang, Haili; Wu, Yue; Wu, Lingling; Ling, Huayun; Ye, Dong-Qing; Wang, Bin.

Afiliação

Wang H; Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.
Wang T; Anhui Province Laboratory of Inflammation and Immune Mediated Diseases, Hefei, Anhui, China.
Wang H; Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.
Wu Y; Anhui Province Laboratory of Inflammation and Immune Mediated Diseases, Hefei, Anhui, China.
Wu L; Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.
Ling H; Anhui Province Laboratory of Inflammation and Immune Mediated Diseases, Hefei, Anhui, China.
Ye DQ; Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.
Wang B; Anhui Province Laboratory of Inflammation and Immune Mediated Diseases, Hefei, Anhui, China.

Postepy Dermatol Alergol ; 39(2): 353-361, 2022 Apr.

Article em En | MEDLINE | ID: mdl-35645665

Palavras-chave

C1q; Trial Sequential Analysis; meta-analysis; polymorphism; systemic lupus erythematosus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Postepy Dermatol Alergol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google